ApoRepair cover photo
ApoRepair

ApoRepair

Recherche en biotechnologie

To save more patients from a heart attack

À propos

ApoRepair is a French biotech company emerging from the National Center for Scientific Research (CNRS) that aims to improve the management of patients in the acute phase of myocardial infarction (MI). Reperfusion of the heart, essential to save the patient's life, generates adverse effects that diminish the expected benefit. Our therapeutic peptide protects the myocardium and improves the effects of reperfusion. This patented technology is based on a collaborative team effort spanning more than 15 years.

Site web
https://aporepair.fr/
Secteur
Recherche en biotechnologie
Taille de l’entreprise
2-10 employés
Siège social
Montpellier
Type
Société cotée en bourse
Fondée en
2023

Lieux

Employés chez ApoRepair

Nouvelles

Pages similaires